National Research (NASDAQ:NRC – Get Free Report) is scheduled to issue its quarterly earnings data after the market closes on Tuesday, May 7th. Persons that are interested in registering for the company’s earnings conference call can do so using this link.
National Research (NASDAQ:NRC – Get Free Report) last announced its quarterly earnings data on Tuesday, February 13th. The company reported $0.36 earnings per share for the quarter. The company had revenue of $38.00 million for the quarter. National Research had a return on equity of 47.79% and a net margin of 20.84%.
National Research Stock Performance
Shares of NASDAQ NRC opened at $34.87 on Friday. The firm has a market capitalization of $831.79 million, a price-to-earnings ratio of 27.90 and a beta of 0.45. National Research has a one year low of $32.08 and a one year high of $47.25. The business has a fifty day simple moving average of $37.57 and a 200 day simple moving average of $39.40. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.60.
National Research Dividend Announcement
Analysts Set New Price Targets
Separately, TheStreet lowered shares of National Research from a “b-” rating to a “c+” rating in a research report on Thursday, January 11th.
View Our Latest Analysis on NRC
About National Research
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.
Featured Articles
- Five stocks we like better than National Research
- How to Invest in Biotech Stocks
- MarketBeat Week in Review – 4/29 – 5/3
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.